JPHC CE: Oral b-Lactam Antibiotics for Pediatric Otitis Media, Rhinosinusitis, and Pneumonia
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is 10$. Acute otitis media, acute bacterial rhinosinusitis, and community- acquired pneumonia are major drivers of pediatric antibiotic consumption. With many available options and the added challenges of navigating antibiotic allergies and de-escalating from intravenous treatment for children requiring hospitalization, prescribing for these relatively simple infections can be a source of confusion and error. The purpose of this article is to evaluate the pharmacokinetic and pharmacodynamic properties of antibiotics commonly prescribed for these disease states, and to specifically compare anti-pneumococcal activity between oral beta-lactams.
J Pediatr Health Care. (2019) V34, Issue 3 pgs. 291−300
Important: This continuing education activity is FREE to NAPNAP Members. You must be logged in to use your NAPNAP Member ID# and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: firstname.lastname@example.org
Copyright © 2019 by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.0 NAPNAP contact hours of which 1.0 contain pharmacology content.
Pediatric-focused advanced practice registered nurses.
- Describe characteristics of antibiotics best suited for treatment of otitis media, sinusitis, and pneumonia.
- Compare pharmacokinetics and pharmacodynamics of oral cephalosporins to amoxicillin and amoxicillin/clavulanate.
- Recognize superiority of amoxicillin-basedregimens over oral cephalosporins for pneumococcal infections.
- Describe nonequivalence of intravenous and oral third-generation cephalosporins for treatment of pencillin-resistant pneumococcal infections.
- Identify situations that may warrant use of oral cephalosporins.
Leah Molloy, Clinical Pharmacist Specialist, Pediatric Infectious Diseases, Department of Pharmacy, Children’s Hospital of Michigan, Detroit Medical Center, Detroit, MI.
Sasha Barron, Clinical Coordinator, Department of Pharmacy, MI. Pediatrics, Wayne State University School of Medicine,Detroit, MI.
Nadia Khan, Clinical Pharmacist, Department of Pharmacy, Children’s Hospital of Michigan, Detroit Medical Center, Detroit, MI.
Evan Abrass, Pediatric Hematology/Oncology and Bone Marrow Transplant Pharmacist, Department of Pharmacy, Seattle Children’s Hospital, Seattle, WA.
Jocelyn Ang, Professor of Pediatrics, Division of Infectious Diseases, Children’s Hospital of Michigan, Detroit Medical Center; Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI.
Nahed Abdel-Haq, Associate Professor of Pediatrics, Division of Infectious Diseases, Children’s Hospital of Michigan, Detroit Medical Center; Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI.
Conflicts of interest: None to report.
Correspondence: Leah Molloy, PharmD, BCIDP, Department of Pharmacy, Children’s Hospital of Michigan, 3901 Beaubien, Detroit, MI 48322
- 1.00 Contact hours